Boston Scientific Corporation (NYSE:BSX) will report its next earnings on 2-Feb-17. The company reported the earnings of $0.27/Share in the last quarter where the estimated EPS by analysts was $0.27/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.
Many analysts are providing their Estimated Earnings analysis for Boston Scientific Corporation and for the current quarter 25 analysts have projected that the stock could give an Average Earnings estimate of $0.29/share. These analysts have also projected a Low Estimate of $0.28/share and a High Estimate of $0.3/share.
In case of Revenue Estimates, 22 analysts have provided their consensus Average Revenue Estimates for Boston Scientific Corporation as 2.16 Billion. According to these analysts, the Low Revenue Estimate for Boston Scientific Corporation is 2.14 Billion and the High Revenue Estimate is 2.19 Billion. The company had Year Ago Sales of 1.98 Billion.
These analysts also forecasted Growth Estimates for the Current Quarter for BSX to be 11.5%. They are projecting Next Quarter growth of 3.6%. For the next 5 years, Boston Scientific Corporation is expecting Growth of 12.41% per annum, whereas in the past 5 years the growth was 30.57% per annum.
Some buy side analysts are also providing their Analysis on Boston Scientific Corporation, where 9 analysts have rated the stock as Strong buy, 12 analysts have given a Buy signal, 5 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 22 Analysts reported that the Price Target for Boston Scientific Corporation might touch $31 high while the Average Price Target and Low price Target is $27.55 and $24 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Boston Scientific Corporation got Upgrade on 1-Sep-16 where investment firm Argus Upgrade the stock from Hold to Buy.
Boston Scientific Corporation closed its last trading session at $22.19 with the gain of 6.4%. The Market Capitalization of the company stands at 32 Billion. The Company has 52-week high of $24.79 and 52-week low of $15.67. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 9.28% where SMA50 and SMA200 are 10.38% and 5.63% respectively. The Company Touched its 52-Week High on Jul 28, 2016 and 52-Week Low on Feb 8, 2016.
The Relative Volume of the company is 2.84 and Average Volume (3 months) is 8.49 million. Boston Scientific Corporation P/E (price to earnings) ratio is 414.21 and Forward P/E ratio of 18.9.
The company shows its Return on Assets (ROA) value of 0.5%. The Return on Equity (ROE) value stands at 1.3%. While it’s Return on Investment (ROI) value is 0.7%.
While looking at the Stock’s Performance, Boston Scientific Corporation currently shows a Weekly Performance of 7.91%, where Monthly Performance is 14.56%, Quarterly performance is -0.67%, 6 Months performance is -0.13% and yearly performance percentage is 37.83%. Year to Date performance value (YTD perf) value is 9.15%. The Stock currently has a Weekly Volatility of 2.33% and Monthly Volatility of 1.56%.